Keratins Gone Bad: A Look at the Causes of a Rare Skin Disease
CSEF · 2006 Biochemistry/ Molecular Biology
Overview
Objectives/Goals PURPOSE My project is to test if a plasmid expressing K16 WT (wild type or normal) protein makes filaments (chains of keratin). In addition, I will test to see if a K16 mutant plasmid, that contains a mutation identified in a Pachyonychia Congenita patient, disturbs the making of filaments (making aggregates, broken filaments, instead). HYPOTHESIS I hypothesize that if I transfect K16 WT (wild type) fused to Yellow Fluorescent Protein (YFP) into human tissue culture cells, the cell will express strong, normal filaments. If I transfect K16 ÄHTM (mutant) fused to YFP into human tissue culture cells, the cells will form aggregates in place of filaments. Methods/Materials Overall objective: make a fusion between K16 (ÄHTM or WT) and a reporter protein, YFP. Therefore, because YFP can be seen using a fluorescence microscope, the K16 ÄHTM or WT fused to YFP can be seen. 1.Using Recombinant DNA Technology, use restriction enzymes and ligase to insert the K16 PCR fragment into an expression plasmid, which contains YFP. 2.Purify the K16 WT/YFP and the K16 ÄHTM/YFP expression plasmids, and transfect them into human tissue culture cells. 3.Incubate the cells for a few days to allow the cells to make K16 WT and K16 ÄHTM proteins. 4.Look under a fluorescence microscope for filaments and aggregates. Conclusions/Discussion My hypothesis was correct the K16 ÄHTM/YFP plasmids that were transfected into human tissue culture cells made aggregates and the K16 WT/YFP plasmids made filaments when transfected into human tissue culture cells. According to the results, it is possible that the broken filaments, or aggregates, cause people with the deletion mutation to have the symptoms of Pachyonychia Congenita patients. The results are not as clear as I thought they would be. Although the difference between filaments and aggregates was clear, I was surprised that there was a mix of filaments and aggregates in the cells transfected with K16 ÄHTM (mutant) protein. Furthermore, there were some variations of the K16 WT (wild type) cells which contained a few aggregates.
Summary statement
My project was to look at the effects of a rare skin disease mutation in keratin cells.
Help received
Transderm, Inc. helped with project plan, supplies, and equipment; Somagenics, Inc. also procided necesary equipment; Dr. Francis Smith at University of Dundee, Scotland provided the K16 mutant and wildtype constructs; Dr. Michael Dalbey at the University of California Santa Cruz allowed me to use a
Competition history
- CSEF 2006
Resources
Related projects
CSEF · 2010
In vitro Analysis of a Synthetic Protein: A Model for Enzyme Replacement Therapy
CSEF · 2013
A Molecular Study of Ror2/Wnt Signaling Pathways and Their Effects on Facial Deformities During Embryonic Development
CSEF · 2011
Therapeutic Natural Products: Effect of H36A Mutation on Structure and Function of StfQ
CSEF · 2005
pTT Influence on Genetic Change of Human Fibroblasts and Prokaryotes Exposed to UV Light
CSEF · 2008
Construction of an IGF-NAGLU Fusion Protein for Treatment of Sanfilippo B Syndrome
CSEF · 2017
Spectral Phasor Protein Characterization of Huntington's Disease for Early Onset Diagnosis
CSEF · 2010
Male Pattern Baldness: The Hair Growth Cycle and Genetic Mutations
CSEF · 2005
Nail-Patella Syndrome Phenotype Expression and Inheritance of LMX1B Gene Mutation
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects